Loading stock…

Shanghai United Imaging Healthcare Co., Ltd. (688271) Stock Verdict & Ratings | Investment Bastion

Stock Verdict·Updated 1d ago

Shanghai United Imaging Healthcare Co., Ltd.

688271Market cap $13BPrice $15.9

Country🇨🇳China

SectorHealthcare

IndustryHealthcare Equipment

Builds MRI machines, CT scanners, and PET systems that compete head-on with GE and Siemens on their own turf. Broke China's decades-long reliance on foreign imaging equipment, now exporting high-end scanners to over 75 countries worldwide.

In Bastion Portfolios?

52W Return-21%Global Market +16%?

01Key Ratings

How does this stock score across Bastion factors?

Growth

Historical Revenue

Rev CAGR (3y)+14%8

Revenue Forecast

Rev CAGR (1y)+26%9

Rev CAGR (3y)+20%9

Rev CAGR (5y)+15%9

Earnings Forecast

EPS Growth Y+1+21%8

EPS Growth Y+2+28%8

EPS Growth Y+3+33%9

Quality

Margins

EBIT Margin12%5

Net Income Margin12%6

Free Cash Flow Margin-0%3

Debt

Net Debt/EBITDA-2.810

Efficiency

ROE8%4

ROA6%6

Earnings Stability77

GEAR+STRONG77

Overall rating across all five factors

Value

Price Multiples

P/E Ratio (Forward)372

P/E Ratio (Forward 3y)242

P/BV4.04

EV Multiples

EV/EBITDA Fwd262

EV/EBIT Fwd342

Yield

Free Cash Flow Yield-0.1%3

Dividend Yieldna–

Momentum

Short term

1 month return+0%8

3 month return+3%7

YTD return-14%3

Mid term

Price vs 52wHigh67%3

1 year return-29%2

Long term

3 year return+4%3

5 year return-40%2

Risk Shield

Price Risk

Beta0.48

Volatility30%7

Free Cash Flow

Free Cash Flow Margin-0%3

Free Cash Flow Yield-0.1%3

Quality

ROCE8%5

Earnings Stability77

Net Debt/EBITDA-2.810

02Growth

Is it actually growing, and how fast?

688271Shanghai United Imaging Healthcare Co.

Revenue FY25$2.0B

GROWTH RATING↗

VERY STRONG91 / 100

REVENUE GROWTH▾SCORE

Revenue, last 3Y, CAGR+14%8

Revenue, next 1Y+26%9

Revenue, next 3Y, CAGR+20%9

Revenue, next 5Y, CAGR+15%9

EARNINGS FORECAST▾SCORE

EPS growth, FY26E+21%8

EPS growth, FY27E+28%8

EPS growth, FY28E+33%9

GROWTH ASSESSMENT

STRENGTHS

It out-grows 91% of companies worldwide.

Revenue grew 14%/yr over the last 3 years, ahead of 70% of companies worldwide.8/10

Revenue is set to grow 20%/yr over the next 3 years, ahead of most of the market.9/10

Revenue grew 14%/yr over the last 3 years and is set to grow 20%/yr from here.

The runway holds up: revenue is set to grow 15%/yr over five years.9/10

Earnings are set to grow faster than sales (EPS about 28%/yr vs revenue 20%/yr), so margins should widen.

WATCH

None flagged.

WEAKNESSES

None flagged.

BOTTOM LINE

Hyper Compounder

A top-tier grower that's speeding up.

03Price Momentum

Is the market behind it right now?

688271Shanghai United Imaging Healthcare Co.

Total return Current−37.8%

Price return Current−38.2%

MOMENTUM RATING↗

WEAK28 / 100

SHORT-TERM RETURNS▾SCORE

1-month return+0%8

3-month return+3%7

YTD return-14%3

MID & LONG-TERM▾SCORE

% of 52-week high67%3

1-year return-29%2

3-year return+4%3

5-year return-40%2

MOMENTUM ASSESSMENT

STRENGTHS

Strong recent results. The stock is outperforming over the past month (+0%) and over three months (+3%).

WATCH

None flagged.

WEAKNESSES

Weak long-term results. It has been a disappointing long-term hold (+3.9% over three years and -40% over five), behind 70% of the market.

It's down 29% over the past year, now 33% below its 52-week high. That is lagging the market.

The stock is underperforming so far this year (-14%).

BOTTOM LINE

Early Turnaround

A poor multi-year track record but a sharp recent rally. Momentum is turning up, yet the trend is young and unproven — it needs follow-through to confirm rather than fade. The one thing to watch: the multi-year record is weak.

04Value

Are you paying a fair price for it?

Stop guessing on United Imaging. Get the full investment case.

Premium

$20.75/month

Billed annually at $249/year $348

✓
Stock VerdictValuation and investment strategy for 4,000+ stocks. Days of hedge fund analyst research, done in 2 minutes.
✓
RadarFind your next investment idea: top-ranked stocks across all 9 Bastion strategies.
✓
Portfolio ManagerCheck if Bastion algorithms added the stock you care about to their portfolios.

Secure via Stripe

Trusted by 1,000+ investors in our community

Loading charts…

02Growth

Is it actually growing, and how fast?

688271Shanghai United Imaging Healthcare Co.

Revenue FY25$2.0B

GROWTH RATING↗

VERY STRONG91 / 100

REVENUE GROWTH▾SCORE

Revenue, last 3Y, CAGR+14%8

Revenue, next 1Y+26%9

Revenue, next 3Y, CAGR+20%9

Revenue, next 5Y, CAGR+15%9

EARNINGS FORECAST▾SCORE

EPS growth, FY26E+21%8

EPS growth, FY27E+28%8

EPS growth, FY28E+33%9

GROWTH ASSESSMENT

STRENGTHS

It out-grows 91% of companies worldwide.

Revenue grew 14%/yr over the last 3 years, ahead of 70% of companies worldwide.8/10

Revenue is set to grow 20%/yr over the next 3 years, ahead of most of the market.9/10

Revenue grew 14%/yr over the last 3 years and is set to grow 20%/yr from here.

The runway holds up: revenue is set to grow 15%/yr over five years.9/10

Earnings are set to grow faster than sales (EPS about 28%/yr vs revenue 20%/yr), so margins should widen.

WATCH

None flagged.

WEAKNESSES

None flagged.

BOTTOM LINE

Hyper Compounder

A top-tier grower that's speeding up.

03Price Momentum

Is the market behind it right now?

688271Shanghai United Imaging Healthcare Co.

Total return Current−37.8%

Price return Current−38.2%

MOMENTUM RATING↗

WEAK28 / 100

SHORT-TERM RETURNS▾SCORE

1-month return+0%8

3-month return+3%7

YTD return-14%3

MID & LONG-TERM▾SCORE

% of 52-week high67%3

1-year return-29%2

3-year return+4%3

5-year return-40%2

MOMENTUM ASSESSMENT

STRENGTHS

Strong recent results. The stock is outperforming over the past month (+0%) and over three months (+3%).

WATCH

None flagged.

WEAKNESSES

Weak long-term results. It has been a disappointing long-term hold (+3.9% over three years and -40% over five), behind 70% of the market.

It's down 29% over the past year, now 33% below its 52-week high. That is lagging the market.

The stock is underperforming so far this year (-14%).

BOTTOM LINE

Early Turnaround

04Value

Are you paying a fair price for it?

Stop guessing on United Imaging. Get the full investment case.

Premium

$20.75/month

Billed annually at $249/year $348

✓
Stock VerdictValuation and investment strategy for 4,000+ stocks. Days of hedge fund analyst research, done in 2 minutes.
✓
RadarFind your next investment idea: top-ranked stocks across all 9 Bastion strategies.
✓
Portfolio ManagerCheck if Bastion algorithms added the stock you care about to their portfolios.

Secure via Stripe

Trusted by 1,000+ investors in our community